Llwytho...
Quizartinib for the treatment of FLT3/ITD acute myeloid leukemia
FLT3/ITD acute myeloid leukemia is a poor prognosis disease driven by a constitutively activated receptor tyrosine kinase, making it an obvious target for drug development. The development of clinically effective FLT3 inhibitors has been slow, in part because many are multi-targeted inhibitors that...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Future Oncol |
|---|---|
| Prif Awdur: | |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2014
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6081740/ https://ncbi.nlm.nih.gov/pubmed/25145428 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fon.14.105 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|